The effect of magnesium on plasma adiponectin and insulin resistance in first-degree relatives of diabetic patients
Early Phase 1
- Conditions
- Diabetes melitus.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201105036296N2
- Lead Sponsor
- Yazd Diabetes Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
inclusion:First-degree relatives of diabetic patients with BMI >25kg/m2
exclusion:1Diabetic patients or first degree relatives with BMI=<25kg/m2 or who consumed Vit D or Zinc supplementation or metformin for past three months
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adiponectin. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Adiponectin kit and the unit is ng/ml.;Insulin. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Insulin Kit and the Unit is mu/lit.
- Secondary Outcome Measures
Name Time Method Fasting Blood Sugar. Timepoint: 12 weeks. Method of measurement: Measurement of blood glucose by Auto analyser method.;Total Cholestrol. Timepoint: 12 weeks. Method of measurement: Measurement of cholestrol by Auto analyser method.;Triglycerid. Timepoint: 12 weeks. Method of measurement: Measurement of triglyceride by Auto Analyser method.;2 hour postprandial blood sugar. Timepoint: 12 weeks. Method of measurement: Measurement of blood glucose by Auto analyser method.;High Density Lipoprotein. Timepoint: 12 weeks. Method of measurement: Measurement of HDL by Auto analyser method.;Low Density Lipoprotein. Timepoint: 12 weeks. Method of measurement: Measurement of LDL by Auto analyser method.